BPC-157 10mg
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a gastric protective protein. Researched for fibroblast proliferation, angiogenesis induction, and tissue repair modulation in connective tissue and GI models.
49,99 €
≥99% HPLC purityThird-party tested · Discreet packaging · Ships from the EU
Specifications
- CAS
- 137525-51-0
- MW
- 1419.5 g/mol
- SKU
- BPC157-10MG
- Storage
- −20 °C, dry, protected from light
Usage Notes
This compound is intended exclusively for in vitro research. Refer to peer-reviewed literature for dosing protocols and experimental methodologies.
Disclaimer: Not for human or animal consumption. Not approved by EMA or FDA.
BPC-157 10mg
Research profile
Overview
BPC-157 is a pentadecapeptide sequence studied across multiple preclinical models for its cytoprotective and tissue-repairing properties. It is derived from a protective protein found in gastric juice and has been the subject of extensive in vitro and in vivo research over the past three decades.
Key Research Areas
-
Angiogenesis
Shown to upregulate VEGF expression and promote new vessel formation in tissue repair models. -
Nitric Oxide System
Interacts with NO-synthase pathways, modulating nitric oxide availability in injured microenvironments. -
Fibroblast Activation
Accelerates fibroblast migration and proliferation in wound healing assays, contributing to collagen matrix deposition. -
Tendon-to-Bone Healing
Studied in musculoskeletal models for reattachment of severed tendons and ligaments. -
GI Mucosal Research
Explored in intestinal permeability and inflammatory bowel models given its gastric origin.
Specifications
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
|---|---|
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.55 g/mol |
| CAS | 137525-51-0 |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilised powder, 10 mg per vial |
For in vitro laboratory research use only. Not for human or animal administration.
Reviews
There are no reviews yet.